Differentiation and malignant transformation: Two roads diverged in a wood

Journal of Cellular Biochemistry

Volumn 76, Issue SUPPL. 32/33, 1999, Pages 68-75

  Baserga, Renato ^a,b   Morrione, Andrea ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; GROWTH FACTOR RECEPTOR; SOMATOMEDIN C RECEPTOR; INSULIN RECEPTOR; SOMATOMEDIN C;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; HEMATOPOIETIC CELL; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RAT; ANIMAL; CELL DIVISION; CELL TRANSFORMATION; CYTOLOGY; DRUG EFFECT; GENETICS; HEMATOPOIETIC SYSTEM; HUMAN; PATHOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALIA;

ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; HEMATOPOIETIC SYSTEM; HUMANS; INSULIN-LIKE GROWTH FACTOR I; RECEPTOR, IGF TYPE 1; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION;

EID: 0033255776     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-4644(1999)75:32+<68::aid-jcb9>3.0.co;2-0     Document Type: Article

References (20)

1. Baserga R, Hongo A, Rubini M, Prisco M, Valentinis B. 1997. The IGF-I receptor in cell growth, transformation and apoptosis. Biochim Biophys Acta 1332:105-126.
2. Baserga R, Prisco M, Hongo A. 1999. IGFs and cell growth. In: Rosenfeld RG, Roberts CT Jr, editors. The IGF system. Totowa, NJ: Humana Press, p 329-353.
3. Borregaard N, Cowland JB. 1998. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89:3503-3521.
4. Carpenter G, Stoscheck CM, Soderquist AM. 1982. Epidermal growth factor. Ann NY Acad Sci 397:11-17.
5. D'Ambrosio C, Valentinis B, Prisco M, Reiss K, Rubini M, Baserga R. 1997. Protective effect of the IGF-I receptor on apoptosis induced by okadaic acid. Cancer Res 57:3264-3271.
6. Eves EM, Kwon J, Downen M, Tucker MS, Wainer BH, Rosner MR 1994. Conditional immortalization of neuronal cells from postmitotic cultures and adult CNS. Brain Res 656:396-404.
7. Fambrough D, McClure K, Kazlauskas A, Lander ES. 1999. Diverse signaling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, set of genes. Cell 97:727-741.
8. Gartel AL, Tyner AL. 1999. Transcriptional regulation of the p21(WAF1/CIP1) gene. Exp Cell Res 246:280-289.
9. Gronborg M, Wulff BS, Rasmussen JS, Kjeldsen T, Gammeltofl S. 1993. Structure-function relationship of the insulin-like growth factor I receptor tyrosine kinase. J Biol Chem 268:23435-23440.
10. Hongo A, D'Ambrosio C, Miura M, Morrione A, Baserga R. 1996. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor. Oncogene 12:1231-1238.
11. Khosravi-Far R, Solski PA, Clark GJ, Kinch MS, Der CJ. 1995. Activation of Rac1, RhoA and mitogen-activated protein kinases is required for Ras transformation. Mol Cell Biol 15:6443-6453.
12. Li S, Ferber A, Miura M, and Baserga R. 1994. Mitogenicity and transforming activity of the insulin-like growth factor I receptor with mutations in the tyrosine kinase domain. J Biol Chem 269:32558-32564.
13. cip1 in the maintenance of the stem/progenitor cells in vivo. Blood 88:3710-3719.
14. Maruoka Y, Harada H, Mitsuyasu T, Seta Y, Kurokawa H, Kajiyama M and Toyoshima K. 1997. Keratinocytes become terminally differentiated in a process involving programmed cell death. Biochem Biophys Res Commun 238:886-890.
15. Miura M, Surmacz E, Burgaud JL, Baserga R. 1995. Different effects on mitogenesis and transformation of a mutation at tyrosine 1251 of the insulin-like growth factor I receptor. J Biol Chem 270:22639-22644.
16. Moses HL, Tucker RF, Leof EB, Coffey RJJ, Halper J, Shipley GD. 1985. Type-β transforming growth factor is a growth stimulator and growth inhibitor. Cancer Cells 3:65-71.
17. Navarro M, Barenton B, Garandel V, Schnekenburger J, Bernardi H. 1997. Insulin-like growth factor 1 (IGF-I) receptor over-expression abolishes the IGF-I requirement for differentiation and induces a ligand-dependent transformed phenotype in C2 inducible myoblasts. Endocrinology 138:5210-5219.
18. O'Connor R, Kauffmann-Zeh A, Liu Y, Lehar S, Evan GI, Baserga R, Blattler WA. 1997. The IGF-I receptor domains for protection from apoptosis are distinct from those required for proliferation and transformation. Mol Cell Biol 17:427-435.
19. Olson MF, Paterson HF, Marshall CJ 1998. Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1. Nature 394:295-299.
20. Pawson T, Saxton TM 1999. Signaling networks - do all roads lead to the same genes? Cell 97:675-678.